Clinical Trials Directory

Trials / Completed

CompletedNCT03113448

0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy

0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double- Blind, Crossover, Placebo-Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Thammasat University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

To study that 0.075% capsaicin lotion is safe, well tolerated and provide significant pain relief in patients with PDN compared with placebo lotion as a randomized, double- Blind, crossover, placebo-controlled trial

Detailed description

Neuropathy is one of the most common complications in both type 1 and type 2 diabetes mellitus. The most common symptom is a symmetrical, chronic, axonal, length-dependent sensorimotor polyneuropathy. Topical capsaicin formulations are widely used to manage pain. Low-concentration creams, lotions, and patches intended for daily skin application have been available in most countries since the early 1980s. We study 0.075% capsaicin lotion is safe, well tolerated and provide significant pain relief in patients with PDN compared with placebo lotion as a randomized, double- Blind, crossover, placebo-controlled trial for 20 weeks throughout the study in 42 participants. All participants are provided both 0.075% capsaicin lotion and placebo lotion. Each agent will be applied for 8 weeks then stop for 4 weeks, after that another agent will be used for 8 weeks. We keep following up all of them by calling and appointment to get information in effectiveness and adverse effect at 0,2,4,8,12,14,16,20 week, respectively.

Conditions

Interventions

TypeNameDescription
DRUG0.075% Capsaicin LotionTo apply 3-4 times per day, every day until 8 weeks then stop
DRUGplaceboTo apply 3-4 times per day, every day until 8 weeks then stop

Timeline

Start date
2017-01-19
Primary completion
2017-04-21
Completion
2018-01-31
First posted
2017-04-13
Last updated
2018-09-12

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03113448. Inclusion in this directory is not an endorsement.